Reprogenesis Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 36

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Reprogenesis General Information

Description

Developer of tissue engineering technology. The company's technology enables an organ to be created using the patient's own tissue grown over a biodegradable polymer scaffolding. This structure is then re-implanted in the patient to repair and replace a defective organ.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Cambridge, MA
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Cambridge, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reprogenesis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Reprogenesis‘s full profile, request access.

Request a free trial

Reprogenesis Patents

Reprogenesis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-6614800-A Sterile packaging of live material with improved storage characteristics Inactive 29-Jul-1999
WO-2001008630-A2 Sterile packaging of live material with improved storage characteristics Inactive 29-Jul-1999
WO-2001008630-A3 Sterile packaging of live material with improved storage characteristics Inactive 29-Jul-1999
WO-2001008630-A9 Sterile packaging of live material with improved storage characteristics Inactive 29-Jul-1999
AU-3118499-A Soft tissue reconstructor and method of use Inactive 03-Apr-1998 A61L27/3839
To view Reprogenesis’s complete patent history, request access »

Reprogenesis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reprogenesis Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Reprogenesis‘s full profile, request access.

Request a free trial

Reprogenesis FAQs

  • When was Reprogenesis founded?

    Reprogenesis was founded in 1993.

  • Where is Reprogenesis headquartered?

    Reprogenesis is headquartered in Cambridge, MA.

  • What is the size of Reprogenesis?

    Reprogenesis has 36 total employees.

  • What industry is Reprogenesis in?

    Reprogenesis’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Reprogenesis a private or public company?

    Reprogenesis is a Private company.

  • What is Reprogenesis’s current revenue?

    The current revenue for Reprogenesis is .

  • How much funding has Reprogenesis raised over time?

    Reprogenesis has raised $16.5M.

  • Who are Reprogenesis’s investors?

    EW Healthcare Partners, Pappas Capital, Piedmont Venture Partners, and Tekla Capital Management have invested in Reprogenesis.

  • When was Reprogenesis acquired?

    Reprogenesis was acquired on 31-Jul-2000.

  • Who acquired Reprogenesis?

    Reprogenesis was acquired by Curis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process